These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Evidence-based management of ANCA vasculitis. Carruthers D; Sherlock J Best Pract Res Clin Rheumatol; 2009 Jun; 23(3):367-78. PubMed ID: 19508944 [TBL] [Abstract][Full Text] [Related]
9. Clinical management and treatment of vasculitis. Jayne D Springer Semin Immunopathol; 2001; 23(3):267-86. PubMed ID: 11591102 [No Abstract] [Full Text] [Related]
10. Respiratory syncytial virus pneumonitis complicating immunosuppressive treatment for ANCA-positive vasculitis. Jones R; Shah S; MacMahon EE; Goldsmith DJ Nephrol Dial Transplant; 2003 Sep; 18(9):1920-2. PubMed ID: 12937244 [No Abstract] [Full Text] [Related]
11. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. De Groot K; Rasmussen N; Bacon PA; Tervaert JW; Feighery C; Gregorini G; Gross WL; Luqmani R; Jayne DR Arthritis Rheum; 2005 Aug; 52(8):2461-9. PubMed ID: 16052573 [TBL] [Abstract][Full Text] [Related]
12. Adverse effects of therapy for ANCA-associated vasculitis. Turnbull J; Harper L Best Pract Res Clin Rheumatol; 2009 Jun; 23(3):391-401. PubMed ID: 19508946 [TBL] [Abstract][Full Text] [Related]
13. [Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis (CYCLOPS study)]. Kötter I Z Rheumatol; 2009 Sep; 68(7):575-7. PubMed ID: 19652987 [No Abstract] [Full Text] [Related]
14. [Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis]. Tervaert JW; Stegeman CA Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2265-7. PubMed ID: 14655291 [TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement. Hu W; Liu C; Xie H; Chen H; Liu Z; Li L Nephrol Dial Transplant; 2008 Apr; 23(4):1307-12. PubMed ID: 18065810 [TBL] [Abstract][Full Text] [Related]
16. The CARI guidelines. Induction and maintenance therapy in ANCA-associated systemic vasculitis. Menahem S; Hiremagalur B; Mudge D; Toussaint N; Walters G; Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S24-36. PubMed ID: 18713121 [No Abstract] [Full Text] [Related]
17. The evolving pathogenesis of systemic vasculitis. Savage CO Clin Med (Lond); 2002; 2(5):458-64. PubMed ID: 12448596 [TBL] [Abstract][Full Text] [Related]
19. When should patients with ANCA-associated vasculitis be switched from induction to maintenance therapy? Flossmann O; de Groot K Nat Clin Pract Nephrol; 2007 May; 3(5):236-7. PubMed ID: 17457358 [No Abstract] [Full Text] [Related]
20. Pulse versus daily oral cyclophosphamide in ANCA-associated vasculitis. Levine SM Ann Intern Med; 2010 Jan; 152(1):65; author reply 65. PubMed ID: 20048281 [No Abstract] [Full Text] [Related] [Next] [New Search]